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ABSTRACT
Epilepsy is the main neurological condition in children and adolescents. Unfortunately 
patients with medical refractory epilepsy are more susceptible for clinical complications 
and death. We report a prospectively evaluated cohort of children followed for 
approximately 10 years. Fifty-three of 1012 patients died. Forty-two patients died due 
to epilepsy or its clinical complications and the main causes of death were pneumonia 
(in 16 cases), sepses (in 9 patients), status epilepticus (in 8 patients). In 11 patients cause 
of death was sudden unexpected death in epilepsy (SUDEP). Mental retardation was 
significantly more frequent in patients who did not die from SUDEP. SUDEP may be a 
significant condition associated with mortality in children and adolescents with epilepsy. 
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RESUMO
Epilepsia é uma das condições neurológicas mais comuns em crianças e adolescentes. 
Infelizmente, pacientes com epilepsias refratárias ao tratamento medicamentoso estão 
mais susceptíveis a complicações clínicas e óbito. Neste trabalho reportamos, em uma 
análise prospectiva, um cohort de crianças acompanhadas por aproximadamente dez 
anos. Cinquenta e três de 1012 pacientes foram a óbito. Quarenta e dois pacientes 
morreram em decorrência da epilepsia ou de suas complicações clínicas; as principais 
causas foram pneumonia (16 casos), sepse (9 casos) e estado de mal epiléptico (8 
casos). Em 11 pacientes a causa da morte foi SUDEP. A presença de retardo mental foi 
significantemente associada a mortalidade em crianças e adolescentes com epilepsia.
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Epilepsy in children is a major health 
problem with an incidence ranging from 
20 to 190 cases/100,000 inhabitants1. Epi-
lepsy is associated with a high probability 
of injury and with clinical comorbidities, 
and the reported mortality incidence in 
epileptic individuals is two to three times 
higher than that in the general popu-
lation1,2. The mortality incidence is not 
clearly determined in the development 
countries, but it appears to be more fre-
quent in patients with mental retardation 
or with symptomatic epilepsy3. The lack 
of studies with a large number of pedi-
atric patients, during a long-term period 
and involving standardized case selec-
tion, makes the comparison between the 
studies difficult4. 
Sudden unexpected death in epilepsy 
(SUDEP) is probably the commonest di-
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rect epilepsy-related cause of death. Its incidence has 
been reported to be 1 per 100 person-years in patients 
with intractable epilepsy and 0.35 per 1,000 person-
years in the general population5. There are few reports 
on death risks in the pediatric population solely, and only 
a small number of patients are usually analyzed6,7. We re-
port here the mortality incidence in a cohort of children 
and adolescents with epilepsy, in a Brazilian hospital.
METHOD
This refers to a prospective study that evaluated the 
incidence of epilepsy-related death in a cohort of chil-
dren aged from zero to 18 years, from January 2000 to 
November 2010, in the Clinical Hospital of Ribeirão 
Preto. During the follow-up, patients were evaluated re-
garding the demographic and clinical data - age at ep-
ilepsy onset, epilepsy syndrome, seizure frequency, 
antiepileptic drug therapy (AED) and neurological de-
velopment. All cases with dubious diagnosis of epilepsy 
were excluded from the study. Families were contacted in 
order to elucidate the death causes. Epilepsy etiology was 
classified as symptomatic (with known cause), probably 
symptomatic (with unknown etiology) and idiopathic 
(when clinical and electrographic findings were clearly 
related to an idiopathic syndrome8). Patients with ex-
clusive febrile seizures or with a single seizure were not 
considered in this study. All families that were contacted 
were asked to sign informed consent according to eth-
ical guidelines.
The SUDEP criteria were: [1] Child with epilepsy and 
with recurrent unprovoked seizures; [2] Child who died 
unexpectedly while in a reasonable state of health; [3] 
Death that occurred suddenly; [4] Death that occurred 
during normal activities, under benign circumstances; 
[5] Unknown obvious medical cause of death; [6] Death 
that was not directly caused by status epilepticus. We 
considered probable SUDEP when all the above-men-
tioned criteria were present, but post-mortem data were 
not available. Possible SUDEP was considered when con-
clusive and post-mortem data were lacking8,9.
The data were evaluated by the SPSS statistical pro-
gram and both descriptive and categorical variables (Chi-
square and Student t test) were considered. A p value 
<.05 was considered statistically significant.
RESULTS
A group of 1012 patients aged from zero to 18 years 
were monitored from January 2000 to November 2010. 
Epilepsy in that group was classified as: focal symp-
tomatic (63.7%), probably symptomatic (20.8%) and id-
iopathic (15.5%). Twenty-five patients (3%) were lost 
during the follow-up. Fifty-three patients or 5.6 persons-
year died during the study period; 31 of which were boys. 
The epilepsy onset occurred between birth and 11 years 
of age (mean 1.5 years±2.2). The mean age of death was 
9.2 years±5.7 (range: 2 to 23 years). All patients showed 
symptomatic epilepsy. Almost all patients presented 
daily seizures (71.7%). Weekly seizures occurred in 17% 
of the cases and rare seizures (one to two seizures/year) 
in 11.3% of the patients. Mental retardation was present 
in 92.5% of the patients (being mild in 17%, moderate 
in 20.8%, and severe in 54.7%). All patients were under 
AED treatment: 9.4% of the subjects were being given 
one drug, 28.3% two drugs, 54.7% three drugs, and 7.5% 
four drugs. Serum AED concentrations at the time of 
death were not available.
Image findings revealed diffuse atrophy (32.1%), de-
structive lesions (15.1%), cortical developmental malfor-
mations (9.4%) and gliosis (7.5%). Other lesions included 
mesial temporal sclerosis (in three patients), leucodis-
trophy (in one patient), tuberous sclerosis (in one pa-
tient), hydrocephaly (in one patient), and Dandy-Walker 
Syndrome (in one patient). Normal brain image was ob-
served in 15.1% of the cases. 
The main causes of death were pneumonia (in 16 
cases), sepses (in nine patients) and status epilepticus 
(in eight patients). In each case there was one patient 
who died from head injury, one from cardiac failure, one 
from acute complications due to epilepsy surgery, one 
from drowning, one from pulmonary embolism, one 
from metabolic acidosis, one from falciform anemia, 
one from chemotherapy (a patient with leukemia) and 
one from hemorrhagic cerebrovascular accident (a pa-
tient with mitochondrial epilepsy).
Neither a clinical nor a neurological cause of death 
could be identified in 11 patients and dying of SUDEP 
was considered. Seven patients were found dead in bed 
in the morning or after a daytime sleep and four patients 
died of subtle cardiorespiratory arrest, directly related 
to a seizure.
Comparison between patients with and without 
SUDEP did not show any significant statistical differences 
related to gender, to epilepsy syndrome, to MRI findings, 
to number of AED, to seizure frequency and to seizure 
type (Table). Patients with moderate or severe mental 
development retardation were at a significant greater 
risk of dying from causes other than SUDEP (p=0.02). 
DISCUSSION
The mortality rate in patients with epilepsy is 2-5 
times higher than that found in the general population10. 
Our series consist of a group of children and adolescents 
with epilepsy that had been prospectively evaluated over 
ten years. There were 53 death cases - 11 of SUDEP - in 
the group of 1012 patients. Some authors have reported 
an increase in both children and elderly adults’ mortality, 
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which is usually associated with neurological deficit and 
clinically associated diseases4. Mortality is rare in pa-
tients with idiopathic epilepsies, and that was not ob-
served in our group, although idiopathic epilepsies had 
been observed in 15.5% of our patients. Those observa-
tions suggested that patients with symptomatic epilep-
sies were at greater risk of dying11.
Systemic infections were the main cause of death 
in our group, followed by SUDEP and status epilep-
ticus. In the general population, SUDEP incidence is 
between 1:500 and 1:1,000 person-years, whereas it is 
close to 1:200 for patients with severe forms of epilep-
sies12. SUDEP mechanisms are not well understood and 
the possible factors that involve them may be cardio-
vascular system abnormalities, central apnea or primary 
brain failure, during or just after a seizure13,14. Genetic 
factors related to channel genes in the cardiac muscu-
lature may interfere in its normal depolarization/repo-
larization process, predisposing the subjects to cardiac 
failure, prolonged QT interval, and increased suscepti-
bility to cardiac arrhythmias12.
The incidence of SUDEP in children and adolescents is 
highly variable, but it is thought to be extremely rare15-17. 
Nevertheless, SUDEP had been identified as being the 
cause of mortality in 12% of the children followed over a 
five-year period, suggesting that that incidence may not 
be so rare18.
Factors related to SUDEP in children may be different 
from those observed in adults. The role of mental retar-
dation, of medically refractory epilepsy, of AED poly-
therapy, of subtherapeutic AED levels, of young age and 
of high seizure frequency, and the description of a sei-
zure just before SUDEP still need to be clarified16.
In this study, almost all patients died at home (63% 
died during their sleep) and post-mortem examinations 
were not performed. Therefore, definitive SUDEP could 
not be established. SUDEP is found to be more prev-
alent worldwide than assumed and some authors sug-
gested that verbal autopsy may be the only means of es-
tablishing a possible or probable cause of death19. No 
correlation between the demographic data and the death 
risk was observed, except when developmental delay was 
considered. Patients that died from SUDEP and were not 
sleeping died during a seizure witnessed by parents or 
caregiver. Deaths that were not associated with SUDEP 
were more frequent in patients with moderate or severe 
cognitive and neurological impairment. Camfield and 
Camfield20 realized a long term follow up in a cohort 
of children with symptomatic generalized epilepsy and 
found that outcome was nearly always death or a life of 
dependency, although approximately 30% of the cases 
had seizure remission. Others authors also found an in-
creased risk of unexpected death in patients with ep-
ilepsy, most of the patients with intractable epilepsy21. 
This seems to contribute to our findings that patients 
with symptomatic epilepsy are more susceptible for clin-
ical comorbidities, and hence death. Confirming this 
finding our group demonstrated that patients with re-
fractory epilepsy that became seizure free after epilepsy 
surgery had a lower SUDEP rate22. Other authors dem-
onstrated a higher risk of SUDEP in patients with extra-
temporal epilepsy23.
Although a higher mortality in boys had been re-
ported4,6, we could not confirm that finding. We also did 
not find a relation between the number of AED and the 
risk of SUDEP. Some authors have suggested that poly-
therapy may have been associated with a more severe 
form of epilepsy, not representing a potential risk alone24.
In conclusion, our study has demonstrated that 
SUDEP may be a significant condition associated with 
mortality in children and adolescents with epilepsy and, 
therefore, this risk should be informed to parents. Mea-
sures to minimize SUDEP risks should include seizure 
control, reduction of stress, participation on physical ex-
Table. Demographic data comparing patients with SUDEP and 
other death causes. Statistical analysis: Studant t test (numerical 
data) and χ2 (categorical data). 
SUDEP 
(n=11)
Not SUDEP 
(n=42)
p 
value
Epilepsy onset (years)
  Mean (SD) 1.75 (2.2) 1.5 (2.2) 0.81
Age at death (years)
  Mean (SD) 7.3 (4.1) 9.7 (5.9) 0.23
Number of AED
  One or two (%) 5 (45.5) 15 (35.7) 0.73
  Three or four (%) 6 (55.5) 27 (64.3)
Gender
  Male (%) 5 (45.5) 26 (61.9) 0.49
  Female (%) 6 (55.5) 16 (38.1)
EEG
  Focal (%) 6 (55.5) 29 (69.0) 1.0
  Generalized (%) 2 (18.2) 10 (23.8)
Seizure l
  Focal (%) 4 (36.4) 13 (30.9) 0.73
  Generalized (%) 7 (63.6) 29 (69.1)
Seizure frequency
  Rare (%) 2 (18.2) 4 (9.5) 0.59
  More than once/month (%) 9 (81.8) 38 (90.5)
Mental retardation
  Normal + mild (%) 6 (55.5) 7 (16.7) 0.02
  Moderate + severe (%) 5 (45.5) 35 (83.3)
SUDEP: sudden unexpected death in epilepsy.
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ercises and night supervision25. In this way, correct med-
ication intake to the achievement of an optimal seizure 
control should be encouraged, and other causes of mor-
tality should be prevented, especially in severely mentally 
retarded patients. A long-term follow-up of patients with 
chronic epilepsy and prospective studies in large popula-
tions should be the best way to finally identify the major 
risk factors involved in children and adolescents’ SUDEP.
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